HomePharma

Pharma

Pharma

FDA Approves Neurelis’ VALTOCO Nasal Spray for Seizure Clusters in Children as Young as 2

Life Sciences Times - April 16, 2025

Pharma

MindMed Doses First Patient in Phase 3 Trial of LSD-Based Therapy for Major Depressive Disorder

Life Sciences Times - April 15, 2025

Pharma

Scipher Medicine and Kythera Labs Join Forces to Advance Precision Treatment for Autoimmune Diseases

Life Sciences Times - April 15, 2025

Pharma

Pfizer Halts Development of Oral Weight Loss Drug Danuglipron

Life Sciences Times - April 14, 2025

Pharma

Pheast Therapeutics Begins Phase 1 Trial of Macrophage Checkpoint Inhibitor PHST001 for Advanced Solid Tumors

Life Sciences Times - April 14, 2025

Pharma

Rocket Pharmaceuticals Announces FDA Lifts Clinical Hold on Danon Disease Trial of RP-A501

Life Sciences Times - August 16, 2021 0

Pharma

Tenax Announces New Publication Highlighting Novel Levosimendan Mechanism of Action in Pulmonary Hypertension Patients

Life Sciences Times - August 12, 2021 0

Pharma

Human studies begin on artificial Intelligence discovered COVID-19 treatment with up to 97 percent effectiveness

Life Sciences Times - August 11, 2021 0

Pharma

SAB Biotherapeutics Announces Nonclinical Data Demonstrating SAB-185 Potently Neutralizes Delta and Lambda SARS-CoV-2 Variants

Life Sciences Times - August 11, 2021 0

Pharma

ATUM Announces Issuance of US Patents Covering Novel Enzymes Critical to Genome Engineering Applications

Life Sciences Times - August 11, 2021 0

Pharma

Avacta Announces First Patient Dosed in AVA6000 Pro-Doxorubicin Phase I Clinical Trial

Life Sciences Times - August 11, 2021 0

Pharma

Sesen Bio Strengthens Executive Leadership Team as the Company Approaches the Potential Approval and Commercial Launch of Vicineum™

Life Sciences Times - August 11, 2021 0

Pharma

SINOVAC Announces Positive Data on Booster Shots of CoronaVac

Life Sciences Times - August 10, 2021 0

Pharma

Dermavant Announces FDA Acceptance for Filing of New Drug Application

Life Sciences Times - August 10, 2021 0

Pharma

Amring Pharmaceuticals Inc. Announces the Approval and Launch of Generic Isoproterenol Hydrochloride Injection USP

Life Sciences Times - August 9, 2021 0

Pharma

Philip Morris International Acquires Inhaled Drug Specialist OtiTopic; Growing Pipeline of “Beyond Nicotine” Inhaled Therapeutic Products

Life Sciences Times - August 9, 2021 0

Pharma

Amring Pharmaceuticals Inc. Announces the Approval and Launch of Generic Isoproterenol Hydrochloride Injection USP

Life Sciences Times - August 6, 2021 0

1...495051...62 Page 50 of 62

Most Read

Alis Biosciences Launches Fund to Unlock $30 Billion in Trapped Capital from Struggling Biotech Firms

April 18, 2025

$2.25 Million Settlement Reached in Effexor XR® Class-Action Lawsuit Involving Teva Pharmaceuticals

April 18, 2025

Tempus Forms Advisory Board of Leading Physicians to Guide AI-Driven Precision Medicine

April 18, 2025

Beneath the biotech boom

April 17, 2025

EDITOR PICKS

Beneath the biotech boom

April 17, 2025

Podimetrics and HealthMed Partner to Expand Diabetes Complication Prevention for Employers and Healthcare Systems

April 17, 2025

Novartis to Invest $23 Billion in Expanding U.S. Manufacturing and Research Footprint

April 13, 2025

THIS WEEK'S STORIES

$5M Gift to Support Scholarships at New ASU Medical School

April 14, 2025

Commonwealth Healthcare Corporation Adopts MEDITECH Expanse to Enhance Patient-Centered Care Across Northern Mariana Islands

April 17, 2025

Beneath the biotech boom

April 17, 2025

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Contact us: [email protected]

FOLLOW US

© Newspaper WordPress Theme by TagDiv